RELEReleases

PLT Health Solutions Targets Longevity Market at SupplySide Global 2026

With over 30 branded ingredients slated for display, PLT Health Solutions is shifting the industry conversation toward Experiential Longevity at the upcoming SupplySide Global expo in Las Vegas. From October 26–30, the company will debut new clinical research alongside a proof-of-concept beverage designed to showcase functional performance.

Bio & NewsSeptember 29, 2026675 reads0

The company’s centerpiece is its Experiential Longevity platform, a strategy aimed at translating cellular health into tangible physical benefits. By moving beyond traditional biological markers, PLT focuses on how consumers maintain vitality, mobility, and cognitive sharpness throughout the aging process. This approach is anchored by key ingredients such as the Kinexa Joint Longevity Complex, which targets cartilage integrity, and Nutricog, a complex designed to support neuroimmune balance and memory function.

To demonstrate these solutions in practice, the company is launching a 12-ounce ready-to-drink beverage titled MANGO TANGO, featuring the non-stimulant energy ingredient Zynamite S. Attendees can further explore these formulations at the company's dedicated Experience Zone, which offers interactive demonstrations of ingredients designed for mood, sports nutrition, and physical stamina. Dr. Jeremy Appleton, Director of Medical and Scientific Affairs, will elaborate on the clinical framework behind these products during a presentation on October 28 at the Product Development Theater.

Jennifer Murphy, Head of Innovation and Clinical Science, emphasized that the goal is to provide formulators with tools that address the root causes of aging while delivering immediate, consumer-facing results. According to Steve Fink, Vice President of Marketing, the booth at location #4855 will serve as a hub for both startups and established brands seeking to integrate clinically backed, beverage-friendly ingredients into their portfolios.

Comments (0)

Leave a comment

No comments yet. Be the first!